ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 113 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $155,000 | – | 29,095 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 3,540,777 | $25,033,293 | 35.12% |
| Invus Financial Advisors, LLC | 1,007,575 | $7,123,555 | 7.98% |
| Nextech Invest Ltd. | 5,285,714 | $37,369,998 | 6.29% |
| VR Adviser, LLC | 4,394,527 | $31,069,306 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,075,812 | $7,605,991 | 1.79% |
| First Turn Management, LLC | 1,515,960 | $10,717,837 | 1.74% |
| Frazier Life Sciences Management, L.P. | 4,142,855 | $29,289,985 | 1.37% |
| Altium Capital Management LP | 405,000 | $2,863,350 | 1.17% |
| COMMODORE CAPITAL LP | 2,000,000 | $14,140,000 | 0.96% |
| Euclidean Capital LLC | 989,410 | $6,995,129 | 0.88% |